Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 420.00
+5.55 (1.34%)
Jul 31, 2026, 3:29 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 25.81 billion as of July 31, 2026. Its market cap has increased by 2.22% in one year.
Market Cap
25.81B
Enterprise Value
24.64B
Revenue
6.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
420.00
ChartMarket Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 25.81B, an increase of 22.48%. That is a compound annual growth rate of 0.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 25.81B | 12.00% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 689.42B |
| Anthem Biosciences | 455.74B |
| OneSource Specialty Pharma | 185.69B |
| Concord Biotech | 148.64B |
| Blue Jet Healthcare | 118.53B |
| Supriya Lifescience | 69.78B |
| Zota Health Care | 44.31B |
| Dishman Carbogen Amcis | 29.31B |